Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
No Fixed Assets in the last few periods;
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024
Compare Balance Sheet Results of Kabra Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
23.71
3.18
20.53
645.60%
Share Warrants & Outstandings
Total Reserve
0.95
37.70
-36.75
-97.48%
Shareholder's Funds
24.65
40.88
-16.23
-39.70%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.33
-0.33
-100.00%
Secured Loans
0.00
0.33
-0.33
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
0.07
-0.07
-100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
0.41
-0.41
-100.00%
Current Liabilities
Trade Payables
0.00
2.80
-2.80
-100.00%
Other Current Liabilities
0.14
2.31
-2.17
-93.94%
Short Term Borrowings
0.44
1.48
-1.04
-70.27%
Short Term Provisions
0.00
0.01
-0.01
-100.00%
Total Current Liabilities
0.57
6.60
-6.03
-91.36%
Total Liabilities
25.23
47.88
-22.65
-47.31%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.05
4.03
-3.98
-98.76%
Less: Accumulated Depreciation
0.01
1.68
-1.67
-99.40%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.04
2.35
-2.31
-98.30%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.02
0.13
-0.11
-84.62%
Other Non Current Assets
0.00
0.06
-0.06
-100.00%
Total Non-Current Assets
0.07
2.54
-2.47
-97.24%
Current Assets Loans & Advances
Current Investments
0.00
2.51
-2.51
-100.00%
Inventories
0.00
1.52
-1.52
-100.00%
Sundry Debtors
0.60
7.46
-6.86
-91.96%
Cash and Bank
21.30
2.53
18.77
741.90%
Other Current Assets
0.00
0.35
-0.35
-100.00%
Short Term Loans and Advances
3.26
30.96
-27.70
-89.47%
Total Current Assets
25.16
45.34
-20.18
-44.51%
Net Current Assets (Including Current Investments)
24.59
38.74
-14.15
-36.53%
Total Current Assets Excluding Current Investments
25.16
42.82
-17.66
-41.24%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
25.23
47.88
-22.65
-47.31%
Contingent Liabilities
0.49
1.45
-0.96
-66.21%
Total Debt
0.44
1.81
-1.37
-75.69%
Book Value per share (adjusted)
10.40
128.61
-118.21
-91.91%
Annual - Borrowings
Borrowings 0.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.04 Cr
in Mar 2025Figures in Cr
No Fixed Assets in the last few periods;
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 25.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024






